Tech Company Financing Transactions
ArcherDX Funding Round
ArcherDX closed a $55 million Series C funding round on 12/19/2019. Backers included Perceptive Advisors, ArrowMark Partners and Boulder Ventures.
Transaction Overview
Company Name
Announced On
12/19/2019
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series C
Investors
Perceptive Advisors (Lead Investor) (Michael Altman)
Boulder Ventures (Kyle Lefkoff)
Proceeds Purpose
The firm will use the proceeds to expand its global commercial footprint.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2477 55th St. 202
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
ArcherDX addresses the bottlenecks associated with using NGS in translational research by offering a robust platform for targeted sequencing applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Myers
Chief Medical Officer
Todd Druley
Chief Scientific Officer
Josh Stahl
VP - Bus. Development
Matthew Franklin
VP - General Counsel
Benjamin Carver
VP - Human Resources
Karen Fritschen
VP - Operations
Richard Sjogren
VP - Regulatory Affairs
Sandra Close
Browse more venture capital transactions:
Prev: 12/19/2019: HyperBorean venture capital transaction
Next: 12/19/2019: Domio venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs